Tag: Vifor Pharma

March 28, 2022 Off

Publication of definitive end result for Vifor Pharma tender offer

By Dino Mustafić

CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of CSL Limited (ASX: CSL; USOTC: CSLLY), have announced the definitive notice of the end result of its public tender offer to acquire all publicly held shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348) for USD 179.25 per share as indicated in the offer prospectus of 18 January 2022.